The purpose of this research study titled ‘Live Cell Imaging Market - Growth, Future Prospects, and Competitive Analysis, 2023 – 2030’ is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global live cell imaging market. This report presents and analyzes the major trends prevalent in the global live cell imaging market and the market size and forecast.
This report categorizes the global live cell imaging market in terms of products, technologies, usage areas, and geographical distribution. Based on product types, the global live cell imaging market is categorized into devices (microscopes, standalone systems, image-capturing devices, and cell analyzers), consumables (assays, reagents and kits, media, and other consumables), and software. fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high-content analysis (HCA), ratiometric imaging, fluorescence in situ hybridization (FISH), total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE) and others are the chief cell imaging technologies studied in this report. Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies, and Academic and research institutes are the major usage areas for live cell imaging.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global live cell imaging market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the live cell imaging market. The key players profiled in this report are ATTO Corporation, BioTek Instruments, Biological Industries, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, GE Healthcare, Enzo Life Sciences, Leica Microsystems, Nikon Corporation, Olympus Corporation, PerkinElmer, Thermo Fisher Scientific, and ZEISS International.
Live cell imaging devices currently hold the largest revenue share in the global market. Products such as microscopes, standalone systems, and cell analyzers have always been in high demand across all the fields of pharmaceutical and biotechnology research. Capital costs of imaging devices is the highest among the considered products along with the respective installation and maintenance expenditure. Moreover, as novel technologies are coming in picture, there has been a gradual trend observed in upgrading and replacement of old imaging devices, thus driving the demand upsurge in technologically advanced device systems. On the other hand, consumables such as assays, reagents and kits, and other media and consumables are anticipated to have the largest traded volume in the market. Technological advancement and introduction of novel kits and assays will majorly determine the market growth of this segment.
The live cell imaging market is studied for the following techniques:
Among the considered technologies fluorescence resonance energy transfer (FRET) accounted for the largest revenue share of the market. The market is anticipated to witness robust growth during the forecast period due to ever rising prevalence of chronic diseases, growth in demand for imaging techniques with determining spatial proximity at protein level and proliferation of related industries such as pharmaceuticals (drug discovery) and biotechnology. Growth in demand for monoclonal antibodies, and rising research and development budgets of pharmaceutical and biotechnology companies will add to the growth of this market. Furthermore, adoption of high content screening for research purposes, in personalized medicine will be the highest in Asia Pacific markets, on the ground of growing research outsourcing in the region. On the other hand, high costs and lack of skilled technicians will likely hold back the growth of this market.
Geographically, the global live cell imaging market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
North America currently dominates the global live cell imaging market. Existence of developed pharmaceutical and biotechnology research infrastructure is the prime contributor to the dominance of the region on the global front. Intensive funding for research and development touting novel drug and biotechnology discoveries in the region is an additional market driver. On the other hand, Asia Pacific is the fastest progressing market for live cell imaging. Growth in R&D initiatives in the region and further proliferation of contract research outsourcing to of Asia Pacific live cell imaging market. Additionally, Europe market will majorly witness growth on the ground of trend of perpetual adoption of latest life science technologies in Western Europe.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Live Cell Imaging market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Product
| |
Technology
| |
Usage Area
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
